1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
Species | Human |
Synonyms | 4-1BB Ligand, TNFSF9, CD137L |
Accession | P41273-1 |
Concentration | >95% by SDS-PAGE |
Amino Acid Sequence | Arg71-Glu254, with N-terminal Fc |
Expression System | HEK293 |
Molecular Weight | 43-55kDa (Reducing) |
Endotoxin | <0.1EU/μg |
Conjugation | Unconjugated |
Tag | Human IgG1 Fc |
Physical Appearance | Lyophilized Powder |
Storage Buffer | PBS, PH7.4, 5% trehalose,5% mannitol |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Reference | 1.Cancer Res.2019 Feb 15;79(4):783-794. |
Background
The 4-1BB ligand (4-1BBL), also known as CD137L, is a type II transmembrane protein that is part of the TNF superfamily. 4-1BBL is the high affinity ligand of 4-1BB. Its receptor, CD137/4-1BB, is found on a variety of cells, including inflamed endothelial cells, where its expression enhances extravasation of CD137L expressing monocytes. 4-1BB Ligand is expressed by activated B cells, monocytes, macrophages, dendritic cells (DC), T cells, lymphoma and multiple myeloma cells, hematopoietic stem cells, early myeloid progenitors, neurons, and astrocytes. 4-1BBL induces the proliferation of activated peripheral blood T-cells. Also, 4-1BBL may have a role in activation-induced cell death (AICD).
Picture
Picture
SDS-PAGE
ELISA
Immobilized 4-1BB/TNFRSF9 His Tag Protein, Human(Cat. No. UA010796) at 2.0μg/mL (100μL/well) can bind 4-1BB Ligand/TNFSF9 Fc Chimera Protein, Human (Cat. No. UA011048) with EC50 of 0.70-0.78 ng/ mL.
